<article article-type="research-article" dtd-version="1.4" xml:lang="en"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Discov Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Discov Oncol</journal-id><journal-id journal-id-type="pmc-domain-id">4139</journal-id><journal-id journal-id-type="pmc-domain">discon</journal-id><journal-title-group><journal-title>Discover Oncology</journal-title></journal-title-group><issn pub-type="epub">2730-6011</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12917073</article-id><article-id pub-id-type="pmcid-ver">PMC12917073.1</article-id><article-id pub-id-type="pmcaid">12917073</article-id><article-id pub-id-type="pmcaiid">12917073</article-id><article-id pub-id-type="pmid">41593219</article-id><article-id pub-id-type="doi">10.1007/s12672-026-04520-4</article-id><article-id pub-id-type="publisher-id">4520</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Systemic analysis of 1,4-dichlorobenzenes effects on lung adenocarcinoma environmental exposure and core target regulation prediction</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Ma</surname><given-names initials="B">Bingfeng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Hu</surname><given-names initials="J">Juan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ren</surname><given-names initials="D">Dingfei</given-names></name><address><email>dfeiren@126.com</email></address><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ding</surname><given-names initials="X">Xuansheng</given-names></name><address><email>1020030749@cpu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00q9atg80</institution-id><institution-id institution-id-type="GRID">grid.440648.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0477 188X</institution-id><institution>Department of Immunology, School of Medicine, </institution><institution>Anhui University of Science and Technology, </institution></institution-wrap>Huainan, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/059gcgy73</institution-id><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Lianyungang Second People’s Hospital Affiliated to Kangda College of Nanjing Medical University, </institution></institution-wrap>Lianyungang, China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05xceke97</institution-id><institution-id institution-id-type="GRID">grid.460059.e</institution-id><institution>Lianyungang Clinical College, Bengbu Medical University &amp; The Second People’s Hospital of Lianyungang, </institution></institution-wrap>Lianyungang, China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00q9atg80</institution-id><institution-id institution-id-type="GRID">grid.440648.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0477 188X</institution-id><institution>Joint Research Center for Occupational Medicine and Health of IHM, </institution><institution>Anhui University of Science and Technology, </institution></institution-wrap>Huainan, China </aff><aff id="Aff5"><label>5</label>Occupational Control Hospital of Huaihe Energy Group, Huainan, China </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01sfm2718</institution-id><institution-id institution-id-type="GRID">grid.254147.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 9776 7793</institution-id><institution>School of Pharmacy, </institution><institution>China Pharmaceutical University, </institution></institution-wrap>Nanjing, China </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>1</month><year>2026</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2026</year></pub-date><volume>17</volume><issue-id pub-id-type="pmc-issue-id">503859</issue-id><elocation-id>339</elocation-id><history><date date-type="received"><day>19</day><month>11</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2026</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>01</month><year>2026</year></date></event><event event-type="pmc-live"><date><day>20</day><month>02</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2026-02-20 00:25:15.130"><day>20</day><month>02</month><year>2026</year></date></event></pub-history><permissions><copyright-statement>© The Author(s) 2026</copyright-statement><copyright-year>2026</copyright-year><license><ali:license_ref content-type="ccbyncndlicense" specific-use="textmining" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" xmlns:xlink="http://www.w3.org/1999/xlink">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="12672_2026_Article_4520.pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/><abstract abstract-type="structured" id="Abs1"><sec><title>Objective</title><p id="Par1">To investigate the effects of 1,4-dichlorobenzene (1,4-DCB) on lung adenocarcinoma (LUAD) and elucidate its potential molecular mechanisms, thereby providing a basis for related LUAD risk assessment and intervention.</p></sec><sec><title>Methods</title><p id="Par2">An integrated pipeline combined network toxicology, molecular docking, and immune multi-omics. After retrieving 1,4-DCB–LUAD intersection targets from multiple public repositories, a protein–protein-interaction network was constructed and pruned with TCGA data to identify core targets. Binding affinities were validated by molecular docking. Expression, prognostic value, and immune infiltration patterns of the core targets were subsequently analyzed. Simultaneously, 1,4-DCB toxicity was characterised and a residential exposure inventory was developed.</p></sec><sec><title>Results</title><p id="Par3">1,4-DCB exhibits moderate acute toxicity (LD50 = 500 mg/kg) and clear carcinogenic potential. The study identified 40 cross-target interactions and 8 core targets. MMP13 (− 5.7 kcal/mol) and CYP1A1 (− 6.7 kcal/mol) demonstrated the strongest binding affinities. MMP13 is overexpressed in lung adenocarcinoma, promoting tumor progression. Associated genes are enriched in extracellular matrix remodeling, inflammatory signaling, and the PI3K-Akt pathway. Conversely, CYP1A1 is downregulated and exhibits tumor-suppressive effects, with its interaction network enriched in cytochrome P450-mediated drug metabolism pathways.</p></sec><sec><title>Conclusion</title><p id="Par4">1,4-DCB may participate in the pathogenesis of LUAD through multiple pathways by interacting with MMP13 and CYP1A1, providing scientific basis for risk assessment, diagnosis, and intervention in LUAD.</p></sec><sec><title>Graphical Abstract</title><p id="Par5">
<graphic id="d33e250" orientation="portrait" position="anchor" xlink:href="12672_2026_4520_Fig1_HTML.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>1,4-dichlorobenzene</kwd><kwd>Lung adenocarcinoma</kwd><kwd>Network toxicology</kwd><kwd>Core target</kwd><kwd>Molecular mechanism</kwd><kwd>Exposure prevention and control</kwd></kwd-group><funding-group><award-group><funding-source><institution>Innovation and Entrepreneurship Project of Anhui University of Science and Technology</institution></funding-source><award-id>2024cx2127</award-id><principal-award-recipient><name name-style="western"><surname>Ma</surname><given-names>Bingfeng</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Lianyungang Science and Technology Bureau 2023 Municipal Key Research and Development Project (Social Development)</institution></funding-source><award-id>SF2321</award-id><principal-award-recipient><name name-style="western"><surname>Hu</surname><given-names>Juan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Lianyungang Anti-Cancer Association 2023 Tumor Prevention and Treatment Science and Technology Development Plan Surface Project</institution></funding-source><award-id>MS202308</award-id><principal-award-recipient><name name-style="western"><surname>Hu</surname><given-names>Juan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Nanjing Medical University Kangda College 2023 Key Research and Development Fund Project</institution></funding-source><award-id>KD2023KYJJ045</award-id><principal-award-recipient><name name-style="western"><surname>Hu</surname><given-names>Juan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Lianyungang 2024 hygiene and health Surface Science and Technology Project</institution></funding-source><award-id>202422</award-id><principal-award-recipient><name name-style="western"><surname>Hu</surname><given-names>Juan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Joint Research Center for Occupational Medicine and Health of IHM</institution></funding-source><award-id>OMH-2023-33</award-id><principal-award-recipient><name name-style="western"><surname>Ren</surname><given-names>Dingfei</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© Springer Science+Business Media LLC, part of Springer Nature 2026</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par6">Lung adenocarcinoma (LUAD) is the most frequently diagnosed histological subtype of lung cancer and remains the leading cause of cancer-related mortality worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. Although tobacco smoke, germ-line variants and ambient particulate matter are well-established risk factors [<xref ref-type="bibr" rid="CR2">2</xref>], accumulating evidence implicates environmental xenobiotics as independent contributors to LUAD initiation [<xref ref-type="bibr" rid="CR3">3</xref>]. Among these, 1,4-dichlorobenzene (1,4-DCB), a halogenated aromatic hydrocarbon ubiquitous in moth repellents, air fresheners and mildewcides [<xref ref-type="bibr" rid="CR4">4</xref>], has been detected in sediments, sewage sludge, ground- and surface water, and agricultural soils [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Multi-route exposure (inhalation, dermal absorption and food intake) results in measurable tissue and blood burdens in the general population [<xref ref-type="bibr" rid="CR7">7</xref>]. Data from the U.S. National Health and Nutrition Examination Survey (NHANES 2007–2012) indicate that the concentration range of 1,4-DCB metabolites in adult urine is 0.12–4.3 µg/g creatinine (95th percentile), with detectable levels in 98% of participants [<xref ref-type="bibr" rid="CR8">8</xref>]. Regarding exposure scenarios, indoor concentrations of 1,4-DCB typically range from 0.5 to 15 µg/m³. In spaces where products containing this compound are frequently used, spatial concentrations may rise to 50–200 µg/m³ [<xref ref-type="bibr" rid="CR5">5</xref>]. Regarding regulatory standards, the U.S. Environmental Protection Agency (EPA) sets a chronic inhalation reference concentration (RfC) of 10 µg/m³, while the EU REACH regulation classifies it as a Category 2 carcinogen. Health risk assessments in Shanghai indicate that the average carcinogenic risk from 1,4-DCB reaches 1.95 × 10⁻⁶, exceeding the U.S. EPA’s acceptable risk threshold (1 × 10⁻⁶), making it one of the primary carcinogenic risk sources in indoor environments [<xref ref-type="bibr" rid="CR9">9</xref>]. Epidemiological investigations have linked chronic 1,4-DCB exposure to endocrine-related gynaecological malignancies [<xref ref-type="bibr" rid="CR10">10</xref>], reduced ovarian mass in female offspring [<xref ref-type="bibr" rid="CR11">11</xref>], adolescent thyroid dysfunction [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR12">12</xref>] and toxic encephalopathy following accidental ingestion [<xref ref-type="bibr" rid="CR13">13</xref>]. Respiratory effects have also been reported [<xref ref-type="bibr" rid="CR14">14</xref>]; however, whether 1,4-DCB directly exhibits carcinogenicity in human lungs and its molecular mechanisms remain unclear, severely hindering the development of relevant health risk assessments and intervention strategies.</p><p id="Par7">Conventional toxicology often interrogates single targets or linear signalling cascades, inadequately capturing the poly-target, poly-pathway complexity of environmental carcinogens. Network toxicology overcomes this limitation by integrating bioinformatics, genomics and systems biology to construct pollutant–target–disease interaction maps that visually articulate toxicity pathways [<xref ref-type="bibr" rid="CR15">15</xref>]. Complementary molecular docking simulations provide atomic-level evidence of pollutant–protein binding affinities, substantiating causal molecular links [<xref ref-type="bibr" rid="CR16">16</xref>]. Previous studies demonstrated that 1,4-DCB provokes oxidative stress, perturbs cell-cycle checkpoints and transforms bronchial epithelial cells in vitro; its metabolite 2,5-dichlorohydroquinone induces DNA double-strand breaks [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Yet a systematic mechanism describing how these events converge toward LUAD is lacking.</p><p id="Par8">Therefore, this study employs a progressive research approach of “target screening-pathway enrichment-core validation-functional analysis” to systematically elucidate the potential role of 1,4-DCB in the pathogenesis of lung adenocarcinoma, thereby providing new insights for the prevention and treatment of lung cancer associated with environmental pollutants.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Retrieval of putative dichlorobenzene targets</title><p id="Par9">The canonical SMILES strings of 1,4-DCB (Clc1ccc(Cl)cc1) and 1,2-DCB (Clc1ccccc1Cl) were downloaded from PubChem (<ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov" xmlns:xlink="http://www.w3.org/1999/xlink">https://pubchem.ncbi.nlm.nih.gov</ext-link>). Putative human targets were predicted by SwissTargetPrediction (<ext-link ext-link-type="uri" xlink:href="https://www.swisstargetprediction.ch" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.swisstargetprediction.ch</ext-link>), SEA (<ext-link ext-link-type="uri" xlink:href="https://sea.bkslab.org" xmlns:xlink="http://www.w3.org/1999/xlink">https://sea.bkslab.org</ext-link>), STITCH (<ext-link ext-link-type="uri" xlink:href="https://stitch-db.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://stitch-db.org/</ext-link>) and PharmMapper (<ext-link ext-link-type="uri" xlink:href="https://www.lilab-ecust.cn/pharmmapper" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.lilab-ecust.cn/pharmmapper</ext-link>). After merging the outputs, gene symbols were standardised with UniProt (<ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.uniprot.org</ext-link>) and duplicates were removed to yield the final dichlorobenzene target list.</p></sec><sec id="Sec4"><title>Collection of LUAD-related targets</title><p id="Par10">“Lung adenocarcinoma” was used as the search term in GeneCards (<ext-link ext-link-type="uri" xlink:href="https://www.genecards.org" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.genecards.org</ext-link>) and OMIM (<ext-link ext-link-type="uri" xlink:href="https://www.omim.org" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.omim.org</ext-link>). Based on the score distribution characteristics in the GeneCards database, the median value was adopted as the screening threshold [<xref ref-type="bibr" rid="CR19">19</xref>] (median: 9.339; post-screening gene scores ranged from 9.343 to 212.189). Extract OMIM entries causally associated with LUAD. Integrate and deduplicate the two lists to establish LUAD-related candidate genes [<xref ref-type="bibr" rid="CR20">20</xref>].</p></sec><sec id="Sec5"><title>Intersection of dichlorobenzene and LUAD targets</title><p id="Par11">The dichlorobenzene and LUAD target sets were uploaded to Venny 2.1 (<ext-link ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny" xmlns:xlink="http://www.w3.org/1999/xlink">https://bioinfogp.cnb.csic.es/tools/venny</ext-link>) to generate a Venn diagram; overlapping genes are considered potential co-associated candidate genes for 1,4-DCB-LUAD.</p></sec><sec id="Sec6"><title>Initial toxicity profiling of 1,4-DCB</title><p id="Par12">Acute toxicity and ADME properties were predicted with ProTox-3.0 (<ext-link ext-link-type="uri" xlink:href="https://tox.charite.de" xmlns:xlink="http://www.w3.org/1999/xlink">https://tox.charite.de</ext-link>) and ADMETlab 2.0 (<ext-link ext-link-type="uri" xlink:href="https://admetmesh.scbdd.com" xmlns:xlink="http://www.w3.org/1999/xlink">https://admetmesh.scbdd.com</ext-link>) using the SMILES string of 1,4-DCB.</p></sec><sec id="Sec7"><title>Protein–protein interaction (PPI) network construction</title><p id="Par13">Intersection targets were imported into STRING 11.5 (<ext-link ext-link-type="uri" xlink:href="https://string-db.org" xmlns:xlink="http://www.w3.org/1999/xlink">https://string-db.org</ext-link>) with the species set to Homo sapiens and a confidence cut-off ≥ 0.4. The resulting PPI network was visualised in Cytoscape 3.9.</p></sec><sec id="Sec8"><title>Preliminary screening of potential oncogenic/oncogene suppressor targets</title><p id="Par14">Transcriptome data and clinical follow-up data for LUAD patients were downloaded from the TCGA database (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/" xmlns:xlink="http://www.w3.org/1999/xlink">https://portal.gdc.cancer.gov/</ext-link>). TCGA-LUAD RNA-seq raw data underwent TPM normalization (correcting for gene length and sequencing depth), resulting in consistent median gene expression levels across samples after normalization. Differentially expressed genes (DEGs) were screened using DESeq2 software with the following criteria: DEGs highly expressed in tumor tissue (log₂FC ≥ 2, padj &lt; 0.05) [<xref ref-type="bibr" rid="CR21">21</xref>] were defined as ‘potential oncogenic DEGs’, while DEGs lowly expressed in tumor tissue (log₂FC ≤ -1, padj &lt; 0.05) [<xref ref-type="bibr" rid="CR22">22</xref>] were defined as ‘potential tumor suppressor DEGs’. padj represents the FDR value adjusted for multiple testing, used to control false positive results. A univariate Cox proportional hazards regression model was used to analyze the association between 40 intersection targets and overall survival. Targets with a Hazard Ratio (HR) &gt; 1 were defined as “risk genes” (potential oncogenic targets), while those with HR &lt; 1 were defined as “protective genes” (potential tumor suppressor targets). Finally, the intersection of “intersection targets - potential oncogenic DEGs - risk genes” was designated as 1,4-DCB candidate genes associated with pro-tumoral risk, while the intersection of “intersection targets - potential tumor-suppressive DEGs - protective genes” was designated as 1,4-DCB candidate genes associated with tumor-protective effects.</p></sec><sec id="Sec9"><title>Functional and pathway enrichment analysis</title><p id="Par15">Imported the differentially expressed genes into the DAVID database (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/" xmlns:xlink="http://www.w3.org/1999/xlink">https://david.ncifcrf.gov/</ext-link>) for Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Upload the target genes from the Venn diagram’s intersection to this database, select the “Homo sapiens” species, and submit the results. Based on ascending p-value order, the top 10 GO categories and KEGG pathways were selected and visualized via the MicroBioinformatics website (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.com.cn/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.bioinformatics.com.cn/</ext-link>). The GO categories included Biological Process (BP), Cellular Component (CC), and Molecular Function (MF).</p></sec><sec id="Sec10"><title>Molecular Docking validation</title><p id="Par16">Crystal structures of candidate proteins were retrieved from the RCSB PDB (<ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.rcsb.org</ext-link>), cleaned (water and ligands removed) and protonated in PyMOL 2.5. The 3-D conformer of 1,4-DCB (SDF) was downloaded from PubChem and converted to PDBQT format with AutoDockTools 1.5.7 (flexible bonds allowed). Docking was performed with AutoDock Vina 1.2.0 using a 20 × 20 × 20 Å grid centred on the active site (exhaustiveness = 27). Poses with binding energy ≤ − 5.0 kcal/mol were considered stable and were visualised with PyMOL.</p></sec><sec id="Sec11"><title>Expression of core targets</title><p id="Par17">TCGA LUAD RNA-seq data and clinical annotations (TNM staging) were analyzed in R 4.3.1. Differential expression between 59 paired tumours and adjacent normal tissues was assessed with edgeR. Diagnostic performance was evaluated with receiver-operating-characteristic (ROC) curves (pROC package); AUC ≥ 0.7 was considered informative and AUC ≥ 0.9 excellent. Association between target expression and pathological stage (T1–T4, N0–N3, M0–M1) was tested with the Kruskal–Wallis test.</p></sec><sec id="Sec12"><title>Statistical analysis</title><p id="Par18">All analyses were conducted in R 4.3.1. Continuous variables are presented as mean ± SD. Group comparisons were performed with Student’s t test or the Kruskal–Wallis test as appropriate. Survival analysis used the Cox proportional-hazards model. Correlations were assessed with Pearson’s test. Statistical significance was set at <italic toggle="yes">P</italic> &lt; 0.05 (two-tailed).</p></sec></sec><sec id="Sec13"><title>Results</title><sec id="Sec14"><title>Toxicological profile of 1,4-DCB</title><p id="Par19">In-silico toxicology predicted 1,4-DCB to be moderately toxic (toxicity class 4; LD₅₀ 500 mg/kg). The molecule is small (MW 147 Da), highly lipophilic (logP 2.99) and devoid of polar surface area (TPSA 0 Å²), allowing ready bioaccumulation (Fig. <xref ref-type="fig" rid="Fig1">1</xref>A). Organ-specific alerts were generated for severe drug-induced liver injury (DILI, ++++), carcinogenicity (+++), ocular corrosion/irritation (+++++) and neurotoxicity (blood–brain-barrier penetration: active). Environmental risk was also flagged as high (ecotoxicity: active) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>B). These data establish a multi-system hazard basis for investigating 1,4-DCB-mediated LUAD.</p><p id="Par20">
<fig id="Fig1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Toxicity analysis of 1,4-DCB. <bold>A</bold>, <bold>B</bold> Toxicity analysis results for 1,4-DCB predicted by ProTox-3.0 and ADMETlab2.0 databases (probability scores: + 0.3–0.5, ++ 0.5–0.7, +++ 0.7–0.9, ++++ 0.9–1.0)</p></caption><graphic id="d33e482" orientation="portrait" position="float" xlink:href="12672_2026_4520_Fig2_HTML.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig>
</p></sec><sec id="Sec15"><title>Target identification</title><p id="Par21">Integrative screening of PharmMapper, SEA, SwissTargetPrediction and STITCH yielded 101 high-confidence human targets of 1,4-DCB (Fig. <xref ref-type="fig" rid="Fig2">2</xref>A). Mining GeneCards and OMIM produced 2,933 LUAD-related genes (Fig. <xref ref-type="fig" rid="Fig2">2</xref>B). Venn analysis (Venny 2.1) intersected these sets to 40 common genes that represent putative molecular mediators of 1,4-DCB-induced LUAD (Fig. <xref ref-type="fig" rid="Fig2">2</xref>C).</p><p id="Par22">
<fig id="Fig2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Acquisition of compounds and disease targets. <bold>A</bold> Acquisition of dichlorobenzene toxicity targets. <bold>B</bold> LUAD disease targets. <bold>C</bold>. Venn diagram showing the intersection of dichlorobenzene and LUAD targets</p></caption><graphic id="d33e515" orientation="portrait" position="float" xlink:href="12672_2026_4520_Fig3_HTML.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig>
</p></sec><sec id="Sec16"><title>Bidirectional prioritisation of 1,4-DCB–LUAD core regulators</title><p id="Par23">The 40 intersecting targets were uploaded to STRING (Homo sapiens, confidence ≥ 0.4) to construct a PPI network representing the putative 1,4-DCB targetome in LUAD (Fig. <xref ref-type="fig" rid="Fig3">3</xref>A-B). Using TCGA-LUAD transcriptomic and survival data, we performed bidirectional screening: Pro-tumourigenic axis: genes over-expressed in tumours (log₂FC ≥ 2, FDR &lt; 0.05) that also exhibited HR &gt; 1 in univariate Cox analysis were intersected with the PPI nodes, yielding four oncogenic hubs: KCNN4, MMP13, KIF11 and CCNA2 (Fig. <xref ref-type="fig" rid="Fig3">3</xref>C). Tumour-suppressive axis: genes under-expressed in tumours (log₂FC ≤ − 1, FDR &lt; 0.05) with HR &lt; 1 were likewise intersected, identifying four protective hubs: CXCL12, MAPK10, CYP1A1 and CYP1A2 (Fig. <xref ref-type="fig" rid="Fig3">3</xref>D). These eight proteins constitute the core bidirectional regulators through which 1,4-DCB may exert its dichotomous effects on LUAD initiation or progression.</p><p id="Par24">
<fig id="Fig3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>PPI network and screening of 1,4-DCB-regulated targets in LUAD. <bold>A</bold> PPI network of 1,4-DCB–LUAD intersecting targets. <bold>B</bold> Compound–target–disease mapping. <bold>C</bold> Venn diagram of tri-layer pro-tumour selection: ① STRING PPI; ② TCGA DEGs (log₂FC ≥ 2, FDR &lt; 0.05); ③ Cox risk genes (HR &gt; 1). <bold>D</bold> Venn diagram of tri-layer tumour-suppressive selection: ① STRING PPI; ② TCGA DEGs (log₂FC ≤ − 1, FDR &lt; 0.05); ③ Cox protective genes (HR &lt; 1)</p></caption><graphic id="d33e551" orientation="portrait" position="float" xlink:href="12672_2026_4520_Fig4_HTML.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig>
</p></sec><sec id="Sec17"><title>Expression and functional characteristics of the potential carcinogenic driver MMP13</title><p id="Par25">To quantify the affinity of 1,4-DCB for the four oncogenic hubs, crystal structures of KCNN4 (PDB: 6D42), MMP13 (5UWK), KIF11 (6TLE) and CCNA2 (7MKX) were docked with the ligand using AutoDock Vina. A heat-map of binding energies revealed MMP13 as the top-ranking target (− 5.7 kcal/mol; Fig. <xref ref-type="fig" rid="Fig4">4</xref>A). The lowest-energy pose located the dichlorobenzene molecule within the S1′ pocket, forming hydrophobic contacts with Val-219, His-222 and Tyr-244 (Fig. <xref ref-type="fig" rid="Fig4">4</xref>B), implying 1,4-DCB may bind to MMP13 and participate in the pathogenesis of LUAD.</p><p id="Par26">TCGA-LUAD data showed MMP13 mRNA to be markedly up-regulated in tumours versus adjacent normal lung (Fig. <xref ref-type="fig" rid="Fig4">4</xref>C). Kaplan–Meier analysis indicated shorter overall survival for patients in the top MMP13-expression tertile (HR = 1.07), although the trend did not reach statistical significance (<italic toggle="yes">P</italic> = 0.658; Fig. <xref ref-type="fig" rid="Fig4">4</xref>D). Nevertheless, ROC curve analysis showed high discriminatory capacity between LUAD tumor and adjacent normal tissues (AUC = 0.911; Fig. <xref ref-type="fig" rid="Fig4">4</xref>E). This result reflects the marked expression difference of MMP13 in LUAD tissues relative to normal tissues, providing a reference for monitoring LUAD progression rather than specific diagnostic utility for 1,4-DCB exposure-driven disease. Expression increased progressively with T stage (T3–T4 &gt; T1–T2; <italic toggle="yes">P</italic> &lt; 0.01) and N stage (N1–N3 &gt; N0; <italic toggle="yes">P</italic> &lt; 0.001), whereas a modest reduction was observed in M1 lesions (Fig. <xref ref-type="fig" rid="Fig4">4</xref>F), possibly reflecting altered transcriptional control during metastasis.</p><p id="Par27">To delineate downstream pathways, 186 genes co-expressed with MMP13 were subjected to enrichment analysis. GO terms were dominated by extracellular-matrix (ECM) organisation, keratinisation and inflammatory responses to antigenic stimuli (Fig. <xref ref-type="fig" rid="Fig4">4</xref>G). Cellular-component analysis localised the products to the extracellular space, cornified envelope and ECM, whereas molecular-function categories highlighted cytokine and interleukin-1 receptor binding as well as metalloendopeptidase activity. KEGG mapping ranked PI3K–Akt signalling, cytokine–cytokine receptor interaction and ECM-receptor interaction as the top three pathways (Fig. <xref ref-type="fig" rid="Fig4">4</xref>H), corroborating a role for MMP13 in ECM remodelling, chronic inflammation and PI3K-driven survival.</p><p id="Par28">
<fig id="Fig4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Oncogenic role of MMP13 in LUAD. <bold>A</bold> Binding-energy heat-map of 1,4-DCB with oncogenic targets. <bold>B</bold> Docked pose of 1,4-DCB in MMP13. <bold>C</bold> MMP13 expression in tumour vs. normal tissue (TCGA). <bold>D</bold> Kaplan–Meier survival curves (high vs. low MMP13). <bold>E</bold> ROC curve (AUC = 0.911). <bold>F</bold> Association with TNM stage. <bold>G</bold>, <bold>H</bold> GO and KEGG enrichment of MMP13-co-expressed genes</p></caption><graphic id="d33e629" orientation="portrait" position="float" xlink:href="12672_2026_4520_Fig5_HTML.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig>
</p></sec><sec id="Sec18"><title>Expression and functional characteristics of the potential tumor suppressor driver CYP1A1</title><p id="Par29">To evaluate whether 1,4-DCB directly engages tumour-suppressive targets, crystal structures of CXCL12 (1A15), MAPK10 (7S1N), CYP1A1 (6UDL) and CYP1A2 (2HI4) were retrieved and docked with the ligand. CYP1A1 exhibited the most favourable binding energy (− 6.7 kcal/mol; Fig. <xref ref-type="fig" rid="Fig5">5</xref>A), inserting the dichlorobenzene ring between Phe-224, Leu-254 and Phe-258 through hydrophobic contacts (Fig. <xref ref-type="fig" rid="Fig5">5</xref>B), indicating that 1,4-DCB may interfere with CYP1A1 function after binding to it and participate in the pathogenesis of LUAD.</p><p id="Par30">Pan-cancer analysis of TCGA repositories revealed marked down-regulation of CYP1A1 in LUAD tissues relative to matched normal lung (Fig. <xref ref-type="fig" rid="Fig5">5</xref>C). Stratifying patients by expression tertile disclosed significantly better overall survival (OS; <italic toggle="yes">P</italic> = 0.043) and progression-free survival (PFS; <italic toggle="yes">P</italic> = 0.024) in the high-CYP1A1 group, whereas disease-specific survival showed a non-significant trend (<italic toggle="yes">P</italic> = 0.235; Fig. <xref ref-type="fig" rid="Fig5">5</xref>D). ROC analysis of CYP1A1 in LUAD tumors and adjacent normal tissues demonstrated its excellent discriminatory performance (AUC = 0.805; Fig. <xref ref-type="fig" rid="Fig5">5</xref>E).</p><p id="Par31">Genes co-expressed with CYP1A1 were enriched for negative regulation of RNA-polymerase-II transcription, extracellular-region constituents and histone deacetylase binding (Fig. <xref ref-type="fig" rid="Fig5">5</xref>F). KEGG profiling identified “drug metabolism—cytochrome P450” as the top-ranking pathway (Fig. <xref ref-type="fig" rid="Fig5">5</xref>G), implying that loss of xenobiotic-clearance capacity may underpin part of the oncogenic response to 1,4-DCB. Collectively, high CYP1A1 expression defines a LUAD subset with favourable OS and PFS, supporting its utility as a protective biomarker and highlighting detoxification failure as a plausible mechanism whereby 1,4-DCB fosters malignant progression.</p><p id="Par32">
<fig id="Fig5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Analysis of CYP1A1 expression in LUAD. <bold>A</bold> Binding-energy heat-map of 1,4-DCB with tumour-suppressive targets. <bold>B</bold> Docked pose of 1,4-DCB in the CYP1A1 active site. <bold>C</bold> CYP1A1 expression in tumour vs. normal tissue (TCGA). <bold>D</bold> Kaplan–Meier curves for OS, PFS and DSS by CYP1A1 expression. <bold>E</bold> ROC curve (AUC = 0.805). <bold>F</bold> GO enrichment of CYP1A1-co-expressed genes. <bold>G</bold> KEGG pathway enrichment (cytochrome P450 pathway highlighted)</p></caption><graphic id="d33e701" orientation="portrait" position="float" xlink:href="12672_2026_4520_Fig6_HTML.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig>
</p></sec><sec id="Sec19"><title>1,4-DCB household exposure screening checklist</title><p id="Par33">Given the carcinogenic risk predicted by this study and the multi-route exposure characteristics of 1,4-DCB, a household exposure risk assessment checklist (Table <xref ref-type="table" rid="Tab1">1</xref>) has been developed to address the widespread use of this substance in consumer products.” This checklist aims to translate calculated toxicological risk predictions into actionable exposure control measures. By defining product identification criteria for 1,4-DCB-containing items, risk levels, and recommended alternatives, it provides practical guidance for public exposure prevention and establishes a closed-loop logical chain from “risk prediction to exposure control,” serving as a reference for subsequent population exposure intervention studies.</p><p id="Par34">
<table-wrap id="Tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Preliminary assessment checklist for household exposure risks to 1,4-dichlorobenzene</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Category</th><th align="left" colspan="1" rowspan="1">Common products</th><th align="left" colspan="1" rowspan="1">Identification criteria for 1,4-DCB</th><th align="left" colspan="1" rowspan="1">Risk level</th><th align="left" colspan="1" rowspan="1">Recommended substitutes</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Mothproofing and Insect Repellents</td><td align="left" colspan="1" rowspan="1">Mothballs, moth flakes, moth cakes</td><td align="left" colspan="1" rowspan="1"><p>Appearance: White solid blocks or flakes, hard texture, strong chemical odor resembling camphor;</p><p>Ingredients: Labels lack clear indication of “natural camphor” or “cedarwood”; vague terms such as “insect repellent” or “mothproof agent” used; no full ingredient disclosure</p></td><td align="left" colspan="1" rowspan="1"><p>★★★</p><p>(High risk)</p></td><td align="left" colspan="1" rowspan="1">Choose products labeled as “100% natural camphor,” “cedar blocks,” “cedar balls,” or “citronella-based repellents”</td></tr><tr><td align="left" colspan="1" rowspan="1">Dehumidifying and Deodorizing Agents</td><td align="left" colspan="1" rowspan="1">Industrial dehumidifier boxes, solid air fresheners, car deodorant sachets</td><td align="left" colspan="1" rowspan="1"><p>Packaging claims: “High-efficiency dehumidification,” “rapid deodorization”;</p><p>Ingredients: Contain explicit terms like “p-dichlorobenzene” or “1,4-dichlorobenzene,” or use ambiguous terms such as “active ingredients” without specification</p></td><td align="left" colspan="1" rowspan="1"><p>★★★</p><p>(High risk)</p></td><td align="left" colspan="1" rowspan="1">Use physical adsorbents such as “silica gel desiccants,” “activated charcoal boxes,” or “natural bamboo charcoal bags” (reusable after sun-drying); ensure daily ventilation (1–2 times per day)</td></tr><tr><td align="left" colspan="1" rowspan="1">Cleaning and Care Products</td><td align="left" colspan="1" rowspan="1">Heavy-duty degreasers, drain cleaners</td><td align="left" colspan="1" rowspan="1"><p>Functional claims: “Removes stubborn grease,” “eliminates odor from pipes”; strong and irritating odor;</p><p>Ingredients: Contain vague chemical descriptors like “aromatic compounds” or “chlorinated solvents”; lack safety certification labels</p></td><td align="left" colspan="1" rowspan="1"><p>★★</p><p>(Moderate risk)</p></td><td align="left" colspan="1" rowspan="1">Replace with mild, plant-based or food-grade cleaners; for drain cleaning, use homemade eco-friendly solutions (e.g., baking soda + vinegar)</td></tr></tbody></table><table-wrap-foot><p>This checklist is developed based on common application scenarios of 1,4-dichlorobenzene [<xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR25">25</xref>], providing practical guidance for exposure reduction. It requires further validation through large-scale household exposure surveys</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec20"><title>Discussion</title><p id="Par35">By integrating network toxicology and computational biology, we have established for the first time a systematic framework elucidating the potential interaction hypothesis between 1,4-DCB exposure and lung adenocarcinoma. This computational approach identifies candidate genes and proposes mechanistic hypotheses, constructing a comprehensive toxicological framework linking environmental exposure to malignant transformation and laying the groundwork for future experimental validation.</p><p id="Par36">In-silico profiling with ProTox-3.0 and ADMETlab 2.0 classified 1,4-DCB as moderately toxic (LD₅₀ 500 mg/kg) and highly lipophilic (logP 2.99), properties that favour pulmonary absorption, bioaccumulation and sustained epithelial insult. The compound was further flagged for respiratory carcinogenicity (+++), hepatotoxicity (++++) and neurotoxicity, supporting its multi-system hazard potential [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Although hepatic and neurological effects lie outside the immediate LUAD trajectory, they may indirectly exacerbate tumourigenesis through systemic inflammation and immune dysregulation, meriting future multi-organ studies.</p><p id="Par37">Intersection of 1,4-DCB target space with LUAD disease genes yielded 40 candidate proteins enriched in “chemical carcinogenesis–receptor activation” and “drug metabolism–cytochrome P450” pathways, concordant with previous reports of oxidative stress and cell-cycle disruption induced by the pollutant [<xref ref-type="bibr" rid="CR28">28</xref>]. Notably, over-representation of xenobiotic metabolism (GO-BP) and P450 pathways (KEGG) implicates detoxification imbalance as a critical mechanistic node, providing a rational basis for interrogating CYP1A1 function.</p><p id="Par38">MMP13 emerged as a putative oncogenic hub. As a collagenase that degrades extracellular matrix (ECM), MMP13 facilitates invasion and metastasis [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Molecular docking revealed high-affinity binding of 1,4-DCB (− 5.7 kcal/mol) within the catalytic cleft, suggesting allosteric activation of proteolytic activity. Clinically, MMP13 over-expression correlated with advanced T and N stages and possesses significant monitoring value (AUC = 0.911).</p><p id="Par39">Conversely, CYP1A1 appears to serve as a detoxification barrier. The enzyme catalyses phase-I metabolism of polycyclic aromatic hydrocarbons and halobenzenes, generating water-soluble derivatives for excretion [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Docking simulations placed 1,4-DCB deep inside the CYP1A1 active site (− 6.7 kcal/mol), engaging Phe-224, Leu-254 and Phe-258—residues critical for substrate recognition and π–π stacking with aromatic xenobiotics [<xref ref-type="bibr" rid="CR33">33</xref>]. Occupancy of this pocket is predicted to competitively inhibit enzymatic turnover, diminish clearance and promote accumulation of 1,4-DCB and its genotoxic metabolite 2,5-dichlorohydroquinone, ultimately eliciting DNA damage and oxidative stress. Concordantly, CYP1A1 was markedly down-regulated in LUAD, and low expression portended poor overall and progression-free survival. Enrichment of “drug metabolism–cytochrome P450” among CYP1A1-co-expressed genes corroborates detoxification failure as a key oncogenic driver. Context-dependency should, however, be acknowledged: whereas CYP1A1 appears protective in lung, hepatic up-regulation has been linked to procarcinogenic bio-activation in liver cancers [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], underscoring tissue-specific and pollutant-specific roles that warrant mechanistic follow-up.</p><p id="Par40">Several limitations should be noted. First, all findings in this study are computational in nature. Toxicity prediction serves as a preliminary screening tool, and experimental toxicological validation will be conducted in the future. To draw any mechanistic conclusions, further validation must be conducted through both in vitro experiments (e.g., treating lung adenocarcinoma cell lines with 1,4-DCB to detect changes in MMP13/CYP1A1 expression and activity) and in vivo experiments (e.g., observing lung tissue carcinogenesis in 1,4-DCB-exposed mouse models). Second, absence of human exposure data—such as urinary or blood concentrations of 1,4-DCB or its metabolites—precludes direct linkage between internal dose and target modulation in patients. Prospective epidemiological studies integrating exposure biomarkers with tumour molecular profiling are therefore essential to translate these findings into population-level risk estimates and preventive strategies. Third, we acknowledge that ligand-based predictors like SwissTargetPrediction exhibit reduced accuracy for simple, hydrophobic molecules, necessitating experimental validation of our computational targets. Fourth, this study predicted the binding mode of 1,4-DCB with core targets through molecular docking but cannot confirm its dynamic interactions in biological systems. Subsequent molecular dynamics (MD) simulations are required to analyze binding stability, while experimental techniques such as Co-IP and SPR should be employed to validate the direct interaction between 1,4-DCB and MMP13/CYP1A1. In addition, this study primarily relies on computationally predicted PPI networks. Although secondary screening using TCGA transcriptomic data and survival analysis minimized bias from predictive interactions, uncertainty cannot be entirely excluded. Future studies should validate direct interactions between key proteins through experiments such as Co-IP.</p></sec><sec id="Sec21"><title>Conclusion</title><p id="Par41">This study employed network toxicology and bioinformatics approaches to propose a potential molecular mechanism hypothesis for 1,4-dichlorobenzene-induced lung adenocarcinoma, identifying MMP13 and CYP1A1 as core candidate targets. Results indicate that 1,4-dichlorobenzene may disrupt detoxification pathways (CYP1A1) and ECM remodeling/immune infiltration (MMP13) by interacting with these targets, providing a framework for future experimental validation. These findings offer insights for risk assessment and early detection strategies of 1,4-dichlorobenzene-associated lung adenocarcinoma, though causality remains unestablished. Further in vitro and in vivo experiments, along with exposure-stratified epidemiological studies, are required to validate the proposed mechanisms.</p></sec></body><back><fn-group><fn><p><bold>Publisher’s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Bingfeng Ma and Juan Hu contributed equally to this work.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>Bingfeng Ma: Writing - original draft, Data curation. Juan Hu: Investigation, Methodology. Dingfei Ren: Resources, Funding acquisition, Writing - review &amp; editing. Xuansheng Ding: Writing - review &amp; editing, Supervision.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was supported by the Joint Research Center for Occupational Medicine and Health of IHM (OMH-2023-33); Innovation and Entrepreneurship Project of Anhui University of Science and Technology(2024cx2127); Lianyungang Science and Technology Bureau 2023 Municipal Key Research and Development Project (Social Development) (SF2321); Lianyungang Anti-Cancer Association 2023 Tumor Prevention and Treatment Science and Technology Development Plan Surface Project (MS202308); Nanjing Medical University Kangda College 2023 Key Research and Development Fund Project (KD2023KYJJ045); and Lianyungang 2024 hygiene and health Surface Science and Technology Project (202422).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated and/or analyzed during the current study are available in the following repositories: RNA sequencing data: Transcriptomic data for lung adenocarcinoma were obtained from The Cancer Genome Atlas (TCGA) repository, project TCGA-LUAD, available at https://portal.gdc.cancer.gov/projects/TCGA-LUAD.Protein structures: The macromolecular structures used for molecular docking are available in the Protein Data Bank (PDB) repository under accession numbers: 6D42 (KCNN4) [https://doi.org/10.2210/pdb6D42/pdb], 5UWK (MMP13) [https://doi.org/10.2210/pdb5UWK/pdb], 6TLE (KIF11) [https://doi.org/10.2210/pdb6TLE/pdb], 7MKX (CCNA2) [https://doi.org/10.2210/pdb7MKX/pdb], 1A15 (CXCL12) [https://doi.org/10.2210/pdb1A15/pdb], 7S1N (MAPK10) [https://doi.org/10.2210/pdb7S1N/pdb], 6UDL (CYP1A1) [https://doi.org/10.2210/pdb6UDL/pdb], and 2HI4 (CYP1A2) [https://doi.org/10.2210/pdb2HI4/pdb].Computational prediction data: Target prediction and toxicity data were derived from publicly accessible web-based tools: SwissTargetPrediction (https://www.swisstargetprediction.ch), SEA (https://sea.bkslab.org), PharmMapper (https://www.lilab-ecust.cn/pharmmapper), ProTox-3.0 (https://tox.charite.de), and ADMETlab 2.0 (https://admetmesh.scbdd.com). No new datasets were generated from these analyses.Other data: All remaining data supporting the findings are included in the article and its supplementary materials.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par42">This study exclusively utilized publicly available human transcriptomic and genomic datasets (e.g., TCGA, GeneCards, OMIM) and computational prediction tools. No human or animal subjects were involved, and no primary data were collected. Therefore, ethical approval was not required. Consent to participate is not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par43">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par44">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><etal/></person-group><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J Clin</source><year>2018</year><volume>68</volume><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.3322/caac.21492</pub-id><pub-id pub-id-type="pmid">30207593</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. 10.3322/caac.21492.<pub-id pub-id-type="pmid">30207593</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.3322/caac.21492</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>P-L</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><etal/></person-group><article-title>DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2</article-title><source>Int Immunopharmacol</source><year>2024</year><volume>142</volume><fpage>113043</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2024.113043</pub-id><pub-id pub-id-type="pmid">39216120</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Li Z, Zhao P-L, Gao X, et al. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2. Int Immunopharmacol. 2024;142:113043. 10.1016/j.intimp.2024.113043.<pub-id pub-id-type="pmid">39216120</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.intimp.2024.113043</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>S-L</given-names></name><name name-style="western"><surname>Chuan</surname><given-names>P-M</given-names></name><name name-style="western"><surname>Lai</surname><given-names>C-H</given-names></name><etal/></person-group><article-title>Greater lung cancer polygenic risk score in higher air pollution areas linked to greater rate of lung adenocarcinoma: a single-centre study in East Asia</article-title><source>BMJ Open Respir Res</source><year>2025</year><volume>12</volume><fpage>e002899</fpage><pub-id pub-id-type="doi">10.1136/bmjresp-2024-002899</pub-id><pub-id pub-id-type="pmid">41083276</pub-id><pub-id pub-id-type="pmcid">PMC12519728</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Chang S-L, Chuan P-M, Lai C-H, et al. Greater lung cancer polygenic risk score in higher air pollution areas linked to greater rate of lung adenocarcinoma: a single-centre study in East Asia. BMJ Open Respir Res. 2025;12:e002899. 10.1136/bmjresp-2024-002899.<pub-id pub-id-type="pmid">41083276</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1136/bmjresp-2024-002899</pub-id><pub-id pub-id-type="pmcid">PMC12519728</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>H-L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z-S</given-names></name><name name-style="western"><surname>Han</surname><given-names>Q</given-names></name><etal/></person-group><article-title>The potential of <italic toggle="yes">Cupriavidus</italic> sp. DF5525 degrading high concentrations of p-dichlorobenzene</article-title><source>J Hazard Mater</source><year>2025</year><volume>497</volume><fpage>139747</fpage><pub-id pub-id-type="doi">10.1016/j.jhazmat.2025.139747</pub-id><pub-id pub-id-type="pmid">40925160</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Ma H-L, Liu Z-S, Han Q, et al. The potential of <italic toggle="yes">Cupriavidus</italic> sp. DF5525 degrading high concentrations of p-dichlorobenzene. J Hazard Mater. 2025;497:139747. 10.1016/j.jhazmat.2025.139747.<pub-id pub-id-type="pmid">40925160</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.jhazmat.2025.139747</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerrero</surname><given-names>PA</given-names></name><name name-style="western"><surname>Corsi</surname><given-names>RL</given-names></name></person-group><article-title>Emissions of p-dichlorobenzene and naphthalene from consumer products</article-title><source>J Air Waste Manag Assoc</source><year>2012</year><volume>62</volume><fpage>1075</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1080/10962247.2012.694399</pub-id><pub-id pub-id-type="pmid">23019821</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Guerrero PA, Corsi RL. Emissions of p-dichlorobenzene and naphthalene from consumer products. J Air Waste Manag Assoc. 2012;62:1075–84. 10.1080/10962247.2012.694399.<pub-id pub-id-type="pmid">23019821</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1080/10962247.2012.694399</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>G</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Biosurfactant-enhanced removal of o,p-dichlorobenzene from contaminated soil</article-title><source>Environ Sci Pollut Res</source><year>2018</year><volume>25</volume><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1007/s11356-016-7711-0</pub-id><pub-id pub-id-type="pmid">27699659</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Pei G, Sun C, Zhu Y, et al. Biosurfactant-enhanced removal of o,p-dichlorobenzene from contaminated soil. Environ Sci Pollut Res. 2018;25:18–26. 10.1007/s11356-016-7711-0.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1007/s11356-016-7711-0</pub-id><pub-id pub-id-type="pmid">27699659</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A new perspective on volatile halogenated hydrocarbons in Chinese agricultural soils</article-title><source>Sci Total Environ</source><year>2020</year><volume>703</volume><fpage>134646</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2019.134646</pub-id><pub-id pub-id-type="pmid">31753494</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Lin X, Xu C, Zhou Y, et al. A new perspective on volatile halogenated hydrocarbons in Chinese agricultural soils. Sci Total Environ. 2020;703:134646. 10.1016/j.scitotenv.2019.134646.<pub-id pub-id-type="pmid">31753494</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.scitotenv.2019.134646</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Volatile organic compounds exposure with risk of thyroid function in U.S. General population: 2007–2012 NHANES</article-title><source>Ecotoxicol Environ Saf</source><year>2025</year><volume>303</volume><fpage>118987</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2025.118987</pub-id><pub-id pub-id-type="pmid">40912098</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Li H, Xiao L, Wang Y, et al. Volatile organic compounds exposure with risk of thyroid function in U.S. General population: 2007–2012 NHANES. Ecotoxicol Environ Saf. 2025;303:118987. 10.1016/j.ecoenv.2025.118987.<pub-id pub-id-type="pmid">40912098</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.ecoenv.2025.118987</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>H</given-names></name><name name-style="western"><surname>Jing</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group><article-title>VOC characteristics and inhalation health risks in newly renovated residences in Shanghai, China</article-title><source>Sci Total Environ</source><year>2017</year><volume>577</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2016.10.071</pub-id><pub-id pub-id-type="pmid">27817926</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Dai H, Jing S, Wang H, et al. VOC characteristics and inhalation health risks in newly renovated residences in Shanghai, China. Sci Total Environ. 2017;577:73–83. 10.1016/j.scitotenv.2016.10.071.<pub-id pub-id-type="pmid">27817926</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.scitotenv.2016.10.071</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name></person-group><article-title>Exposure to <italic toggle="yes">p</italic>-dichlorobenzene and serum α-Klotho levels among US participants in their middle and late adulthood</article-title><source>Sci Total Environ</source><year>2023</year><volume>858</volume><fpage>159768</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2022.159768</pub-id><pub-id pub-id-type="pmid">36309252</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Zhu J, Wei Y. Exposure to <italic toggle="yes">p</italic>-dichlorobenzene and serum α-Klotho levels among US participants in their middle and late adulthood. Sci Total Environ. 2023;858:159768. 10.1016/j.scitotenv.2022.159768.<pub-id pub-id-type="pmid">36309252</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.scitotenv.2022.159768</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pridgen</surname><given-names>GW</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name></person-group><article-title>Exposure to p-dichlorobenzene and prevalent endocrine-related reproductive cancers among US women</article-title><source>Environ Sci Pollut Res Int</source><year>2023</year><volume>30</volume><fpage>78324</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s11356-023-27876-4</pub-id><pub-id pub-id-type="pmid">37269516</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Pridgen GW, Zhu J, Wei Y. Exposure to p-dichlorobenzene and prevalent endocrine-related reproductive cancers among US women. Environ Sci Pollut Res Int. 2023;30:78324–31. 10.1007/s11356-023-27876-4.<pub-id pub-id-type="pmid">37269516</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1007/s11356-023-27876-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name></person-group><article-title>Para-Dichlorobenzene exposure is associated with thyroid dysfunction in US adolescents</article-title><source>J Pediatr</source><year>2016</year><volume>177</volume><fpage>238</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2016.06.085</pub-id><pub-id pub-id-type="pmid">27476635</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Wei Y, Zhu J. Para-Dichlorobenzene exposure is associated with thyroid dysfunction in US adolescents. J Pediatr. 2016;177:238–43. 10.1016/j.jpeds.2016.06.085.<pub-id pub-id-type="pmid">27476635</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.jpeds.2016.06.085</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>A</given-names></name><name name-style="western"><surname>Hildenbrand</surname><given-names>J</given-names></name><name name-style="western"><surname>Gensler</surname><given-names>L</given-names></name><name name-style="western"><surname>Scheiner</surname><given-names>N</given-names></name></person-group><article-title>Paradichlorobenzene toxicity: A case report and systematic review of existing literature</article-title><source>J Acad Consult-Liaison Psychiatry</source><year>2025</year><volume>66</volume><fpage>440</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.jaclp.2025.06.008</pub-id><pub-id pub-id-type="pmid">40571283</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Clark A, Hildenbrand J, Gensler L, Scheiner N. Paradichlorobenzene toxicity: A case report and systematic review of existing literature. J Acad Consult-Liaison Psychiatry. 2025;66:440–50. 10.1016/j.jaclp.2025.06.008.<pub-id pub-id-type="pmid">40571283</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.jaclp.2025.06.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y-F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H-W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Independent and joint effects of volatile organic compounds on pulmonary function in U.S. Adults from NHANES: the mediating role of platelet-to-lymphocyte ratio</article-title><source>Environ Pollut Barking Essex 1987</source><year>2025</year><volume>377</volume><fpage>126473</fpage><pub-id pub-id-type="doi">10.1016/j.envpol.2025.126473</pub-id><pub-id pub-id-type="pmid">40383476</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Wei Y-F, Chen H-W, Liu K, et al. Independent and joint effects of volatile organic compounds on pulmonary function in U.S. Adults from NHANES: the mediating role of platelet-to-lymphocyte ratio. Environ Pollut Barking Essex 1987. 2025;377:126473. 10.1016/j.envpol.2025.126473.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.envpol.2025.126473</pub-id><pub-id pub-id-type="pmid">40383476</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name></person-group><article-title>Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular Docking strategy: acetyl tributyl citrate as an example</article-title><source>Sci Total Environ</source><year>2023</year><volume>905</volume><fpage>167904</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2023.167904</pub-id><pub-id pub-id-type="pmid">37858827</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Huang S. Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular Docking strategy: acetyl tributyl citrate as an example. Sci Total Environ. 2023;905:167904. 10.1016/j.scitotenv.2023.167904.<pub-id pub-id-type="pmid">37858827</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.scitotenv.2023.167904</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Network toxicological and molecular Docking to investigate the mechanisms of toxicity of agricultural chemical thiabendazole</article-title><source>Chemosphere</source><year>2024</year><volume>363</volume><fpage>142711</fpage><pub-id pub-id-type="doi">10.1016/j.chemosphere.2024.142711</pub-id><pub-id pub-id-type="pmid">38964723</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">He J, Zhu X, Xu K, et al. Network toxicological and molecular Docking to investigate the mechanisms of toxicity of agricultural chemical thiabendazole. Chemosphere. 2024;363:142711. 10.1016/j.chemosphere.2024.142711.<pub-id pub-id-type="pmid">38964723</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.chemosphere.2024.142711</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Umemura</surname><given-names>T</given-names></name><name name-style="western"><surname>Takada</surname><given-names>K</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cell proliferation in the livers of male mice and rats exposed to the carcinogen P-dichlorobenzene: evidence for thresholds</article-title><source>Drug Chem Toxicol</source><year>1998</year><volume>21</volume><fpage>57</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.3109/01480549809017851</pub-id><pub-id pub-id-type="pmid">9530531</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Umemura T, Takada K, Schulz C, et al. Cell proliferation in the livers of male mice and rats exposed to the carcinogen P-dichlorobenzene: evidence for thresholds. Drug Chem Toxicol. 1998;21:57–66. 10.3109/01480549809017851.<pub-id pub-id-type="pmid">9530531</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.3109/01480549809017851</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Umemura</surname><given-names>T</given-names></name><name name-style="western"><surname>Tokumo</surname><given-names>K</given-names></name><name name-style="western"><surname>Williams</surname><given-names>GM</given-names></name></person-group><article-title>Cell proliferation induced in the kidneys and livers of rats and mice by short term exposure to the carcinogen p-dichlorobenzene</article-title><source>Arch Toxicol</source><year>1992</year><volume>66</volume><fpage>503</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/BF01970676</pub-id><pub-id pub-id-type="pmid">1359854</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Umemura T, Tokumo K, Williams GM. Cell proliferation induced in the kidneys and livers of rats and mice by short term exposure to the carcinogen p-dichlorobenzene. Arch Toxicol. 1992;66:503–7. 10.1007/BF01970676.<pub-id pub-id-type="pmid">1359854</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1007/BF01970676</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stelzer</surname><given-names>G</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>N</given-names></name><name name-style="western"><surname>Plaschkes</surname><given-names>I</given-names></name></person-group><article-title>The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses</article-title><source>Curr Protoc Bioinforma</source><year>2016</year><volume>54</volume><fpage>1.30.1</fpage><lpage>1.30.33</lpage><pub-id pub-id-type="doi">10.1002/cpbi.5</pub-id><pub-id pub-id-type="pmid">27322403</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinforma. 2016;54:1.30.1–1.30.33. 10.1002/cpbi.5<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/cpbi.5</pub-id><pub-id pub-id-type="pmid">27322403</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>R</given-names></name><name name-style="western"><surname>Quan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Exploring the mechanism of volatile organic compounds in respiratory tract tumors based on network toxicology and molecular simulation</article-title><source>Sci Total Environ</source><year>2025</year><volume>1001</volume><fpage>180500</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2025.180500</pub-id><pub-id pub-id-type="pmid">40972193</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Ding R, Quan Q, Dai Q, et al. Exploring the mechanism of volatile organic compounds in respiratory tract tumors based on network toxicology and molecular simulation. Sci Total Environ. 2025;1001:180500. 10.1016/j.scitotenv.2025.180500.<pub-id pub-id-type="pmid">40972193</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.scitotenv.2025.180500</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Ping</surname><given-names>W</given-names></name></person-group><article-title>Comprehensive analysis of aberrantly expressed profiles of LncRNAs and MiRNAs with associated CeRNA network in lung adenocarcinoma and lung squamous cell carcinoma</article-title><source>Pathol Oncol Res POR</source><year>2020</year><volume>26</volume><fpage>1935</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s12253-019-00780-4</pub-id><pub-id pub-id-type="pmid">31898160</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Dong R, Liu J, Sun W, Ping W. Comprehensive analysis of aberrantly expressed profiles of LncRNAs and MiRNAs with associated CeRNA network in lung adenocarcinoma and lung squamous cell carcinoma. Pathol Oncol Res POR. 2020;26:1935–45. 10.1007/s12253-019-00780-4.<pub-id pub-id-type="pmid">31898160</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1007/s12253-019-00780-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liang</surname><given-names>R</given-names></name><etal/></person-group><article-title>Four-miRNA signature as a prognostic tool for lung adenocarcinoma</article-title><source>OncoTargets Ther</source><year>2018</year><volume>11</volume><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.2147/OTT.S155016</pub-id><pub-id pub-id-type="pmcid">PMC5743192</pub-id><pub-id pub-id-type="pmid">29317831</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Lin Y, Lv Y, Liang R, et al. Four-miRNA signature as a prognostic tool for lung adenocarcinoma. OncoTargets Ther. 2018;11:29–36. 10.2147/OTT.S155016.<pub-id assigning-authority="pmc" pub-id-type="doi">10.2147/OTT.S155016</pub-id><pub-id pub-id-type="pmcid">PMC5743192</pub-id><pub-id pub-id-type="pmid">29317831</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Bu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Indoor exposure levels and risk assessment of volatile organic compounds in residences, schools, and offices in China from 2000 to 2021: A systematic review</article-title><source>Indoor Air</source><year>2022</year><volume>32</volume><fpage>e13091</fpage><pub-id pub-id-type="doi">10.1111/ina.13091</pub-id><pub-id pub-id-type="pmid">36168233</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Liu N, Bu Z, Liu W, et al. Indoor exposure levels and risk assessment of volatile organic compounds in residences, schools, and offices in China from 2000 to 2021: A systematic review. Indoor Air. 2022;32:e13091. 10.1111/ina.13091.<pub-id pub-id-type="pmid">36168233</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1111/ina.13091</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name><name name-style="western"><surname>Mimura</surname><given-names>M</given-names></name><name name-style="western"><surname>Sakon</surname><given-names>N</given-names></name></person-group><article-title>Estimating household exposure to moth repellents <italic toggle="yes">p</italic>dichlorobenzene and naphthalene and the relative contribution of inhalation pathway in a sample of Japanese children</article-title><source>Sci Total Environ</source><year>2021</year><volume>783</volume><fpage>146988</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2021.146988</pub-id><pub-id pub-id-type="pmid">34088142</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Yoshida T, Mimura M, Sakon N. Estimating household exposure to moth repellents <italic toggle="yes">p-</italic>dichlorobenzene and naphthalene and the relative contribution of inhalation pathway in a sample of Japanese children. Sci Total Environ. 2021;783:146988. 10.1016/j.scitotenv.2021.146988.<pub-id pub-id-type="pmid">34088142</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.scitotenv.2021.146988</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chin</surname><given-names>J-Y</given-names></name><name name-style="western"><surname>Godwin</surname><given-names>C</given-names></name><name name-style="western"><surname>Jia</surname><given-names>C</given-names></name><etal/></person-group><article-title>Concentrations and risks of p-dichlorobenzene in indoor and outdoor air</article-title><source>Indoor Air</source><year>2013</year><volume>23</volume><fpage>40</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0668.2012.00796.x</pub-id><pub-id pub-id-type="pmid">22725685</pub-id><pub-id pub-id-type="pmcid">PMC3501547</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Chin J-Y, Godwin C, Jia C, et al. Concentrations and risks of p-dichlorobenzene in indoor and outdoor air. Indoor Air. 2013;23:40–9. 10.1111/j.1600-0668.2012.00796.x.<pub-id pub-id-type="pmid">22725685</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1111/j.1600-0668.2012.00796.x</pub-id><pub-id pub-id-type="pmcid">PMC3501547</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elliott</surname><given-names>L</given-names></name><name name-style="western"><surname>Longnecker</surname><given-names>MP</given-names></name><name name-style="western"><surname>Kissling</surname><given-names>GE</given-names></name><name name-style="western"><surname>London</surname><given-names>SJ</given-names></name></person-group><article-title>Volatile organic compounds and pulmonary function in the third National health and nutrition examination Survey, 1988–1994</article-title><source>Environ Health Perspect</source><year>2006</year><volume>114</volume><fpage>1210</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1289/ehp.9019</pub-id><pub-id pub-id-type="pmid">16882527</pub-id><pub-id pub-id-type="pmcid">PMC1551996</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Elliott L, Longnecker MP, Kissling GE, London SJ. Volatile organic compounds and pulmonary function in the third National health and nutrition examination Survey, 1988–1994. Environ Health Perspect. 2006;114:1210–4. 10.1289/ehp.9019.<pub-id pub-id-type="pmid">16882527</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1289/ehp.9019</pub-id><pub-id pub-id-type="pmcid">PMC1551996</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Igarashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name><name name-style="western"><surname>Ushida</surname><given-names>K</given-names></name><etal/></person-group><article-title>Initial hazard assessment of 1,4-dichlorobutane: genotoxicity tests, 28-day repeated-dose toxicity test, and reproductive/developmental toxicity screening test in rats</article-title><source>Regul Toxicol Pharmacol</source><year>2020</year><volume>112</volume><fpage>104610</fpage><pub-id pub-id-type="doi">10.1016/j.yrtph.2020.104610</pub-id><pub-id pub-id-type="pmid">32032664</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Igarashi T, Suzuki H, Ushida K, et al. Initial hazard assessment of 1,4-dichlorobutane: genotoxicity tests, 28-day repeated-dose toxicity test, and reproductive/developmental toxicity screening test in rats. Regul Toxicol Pharmacol. 2020;112:104610. 10.1016/j.yrtph.2020.104610.<pub-id pub-id-type="pmid">32032664</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.yrtph.2020.104610</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsiao</surname><given-names>P-K</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y-C</given-names></name><name name-style="western"><surname>Shih</surname><given-names>T-S</given-names></name><name name-style="western"><surname>Chiung</surname><given-names>Y-M</given-names></name></person-group><article-title>Effects of occupational exposure to 1,4-dichlorobenzene on hematologic, kidney, and liver functions</article-title><source>Int Arch Occup Environ Health</source><year>2009</year><volume>82</volume><fpage>1077</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1007/s00420-009-0398-5</pub-id><pub-id pub-id-type="pmid">19247685</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Hsiao P-K, Lin Y-C, Shih T-S, Chiung Y-M. Effects of occupational exposure to 1,4-dichlorobenzene on hematologic, kidney, and liver functions. Int Arch Occup Environ Health. 2009;82:1077–85. 10.1007/s00420-009-0398-5.<pub-id pub-id-type="pmid">19247685</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1007/s00420-009-0398-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chan</surname><given-names>KI</given-names></name><etal/></person-group><article-title>The Immunomodulatory role of matrix metalloproteinases in colitis-associated cancer</article-title><source>Front Immunol</source><year>2023</year><volume>13</volume><fpage>1093990</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2022.1093990</pub-id><pub-id pub-id-type="pmid">36776395</pub-id><pub-id pub-id-type="pmcid">PMC9910179</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">He L, Kang Q, Chan KI, et al. The Immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. Front Immunol. 2023;13:1093990. 10.3389/fimmu.2022.1093990.<pub-id pub-id-type="pmid">36776395</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.3389/fimmu.2022.1093990</pub-id><pub-id pub-id-type="pmcid">PMC9910179</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Pritchard</surname><given-names>DM</given-names></name><name name-style="western"><surname>Yu</surname><given-names>L-G</given-names></name></person-group><article-title>Regulation and function of matrix Metalloproteinase-13 in cancer progression and metastasis</article-title><source>Cancers</source><year>2022</year><volume>14</volume><fpage>3263</fpage><pub-id pub-id-type="doi">10.3390/cancers14133263</pub-id><pub-id pub-id-type="pmid">35805035</pub-id><pub-id pub-id-type="pmcid">PMC9265061</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Li S, Pritchard DM, Yu L-G. Regulation and function of matrix Metalloproteinase-13 in cancer progression and metastasis. Cancers. 2022;14:3263. 10.3390/cancers14133263.<pub-id pub-id-type="pmid">35805035</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.3390/cancers14133263</pub-id><pub-id pub-id-type="pmcid">PMC9265061</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>N</given-names></name><name name-style="western"><surname>Irvine</surname><given-names>W</given-names></name></person-group><article-title>In Silico design and SAR study of dibenzyl trisulfide analogues for improved CYP1A1 Inhibition</article-title><source>ChemistryOpen</source><year>2022</year><volume>11</volume><fpage>e202200016</fpage><pub-id pub-id-type="doi">10.1002/open.202200016</pub-id><pub-id pub-id-type="pmid">35610057</pub-id><pub-id pub-id-type="pmcid">PMC9130049</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Clarke N, Irvine W. In Silico design and SAR study of dibenzyl trisulfide analogues for improved CYP1A1 Inhibition. ChemistryOpen. 2022;11:e202200016. 10.1002/open.202200016.<pub-id pub-id-type="pmid">35610057</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/open.202200016</pub-id><pub-id pub-id-type="pmcid">PMC9130049</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Badal</surname><given-names>S</given-names></name><name name-style="western"><surname>Delgoda</surname><given-names>R</given-names></name></person-group><article-title>Role of the modulation of CYP1A1 expression and activity in chemoprevention</article-title><source>J Appl Toxicol</source><year>2014</year><volume>34</volume><fpage>743</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1002/jat.2968</pub-id><pub-id pub-id-type="pmid">24532440</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Badal S, Delgoda R. Role of the modulation of CYP1A1 expression and activity in chemoprevention. J Appl Toxicol. 2014;34:743–53. 10.1002/jat.2968.<pub-id pub-id-type="pmid">24532440</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/jat.2968</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wauchope</surname><given-names>S</given-names></name><name name-style="western"><surname>Roy</surname><given-names>MA</given-names></name><name name-style="western"><surname>Irvine</surname><given-names>W</given-names></name><etal/></person-group><article-title>Dibenzyl trisulfide binds to and competitively inhibits the cytochrome P450 1A1 active site without impacting the expression of the Aryl hydrocarbon receptor</article-title><source>Toxicol Appl Pharmacol</source><year>2021</year><volume>419</volume><fpage>115502</fpage><pub-id pub-id-type="doi">10.1016/j.taap.2021.115502</pub-id><pub-id pub-id-type="pmid">33774063</pub-id><pub-id pub-id-type="pmcid">PMC8372549</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Wauchope S, Roy MA, Irvine W, et al. Dibenzyl trisulfide binds to and competitively inhibits the cytochrome P450 1A1 active site without impacting the expression of the Aryl hydrocarbon receptor. Toxicol Appl Pharmacol. 2021;419:115502. 10.1016/j.taap.2021.115502.<pub-id pub-id-type="pmid">33774063</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.taap.2021.115502</pub-id><pub-id pub-id-type="pmcid">PMC8372549</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>D</given-names></name><name name-style="western"><surname>Radtke</surname><given-names>M</given-names></name><name name-style="western"><surname>Bairlein</surname><given-names>M</given-names></name></person-group><article-title>Highly variable expression of CYP1A1 in human liver and impact on pharmacokinetics of Riociguat and granisetron in humans</article-title><source>Chem Res Toxicol</source><year>2019</year><volume>32</volume><fpage>1115</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrestox.8b00413</pub-id><pub-id pub-id-type="pmid">30950278</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Lang D, Radtke M, Bairlein M. Highly variable expression of CYP1A1 in human liver and impact on pharmacokinetics of Riociguat and granisetron in humans. Chem Res Toxicol. 2019;32:1115–22. 10.1021/acs.chemrestox.8b00413.<pub-id pub-id-type="pmid">30950278</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1021/acs.chemrestox.8b00413</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>B</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>T</given-names></name><etal/></person-group><article-title>CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies</article-title><source>Cancer Sci</source><year>2024</year><volume>115</volume><fpage>3552</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1111/cas.16320</pub-id><pub-id pub-id-type="pmid">39183447</pub-id><pub-id pub-id-type="pmcid">PMC11531955</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Wang Y, Gao B, Jiao T, et al. CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies. Cancer Sci. 2024;115:3552–69. 10.1111/cas.16320.<pub-id pub-id-type="pmid">39183447</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1111/cas.16320</pub-id><pub-id pub-id-type="pmcid">PMC11531955</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>